nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—KCNH2—Sunitinib—pancreatic cancer	0.0626	1	CbGbCtD
Sotalol—Ibuprofen—CXCL8—pancreatic cancer	0.00348	0.504	CrCbGaD
Sotalol—Ibuprofen—PPARG—pancreatic cancer	0.0024	0.348	CrCbGaD
Sotalol—Pain in extremity—Epirubicin—pancreatic cancer	0.00112	0.00138	CcSEcCtD
Sotalol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00111	0.00137	CcSEcCtD
Sotalol—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.0011	0.00137	CcSEcCtD
Sotalol—Visual impairment—Docetaxel—pancreatic cancer	0.0011	0.00137	CcSEcCtD
Sotalol—Dizziness—Tamoxifen—pancreatic cancer	0.0011	0.00137	CcSEcCtD
Sotalol—Hypotension—Irinotecan—pancreatic cancer	0.0011	0.00136	CcSEcCtD
Sotalol—Affect lability—Epirubicin—pancreatic cancer	0.0011	0.00136	CcSEcCtD
Sotalol—Dizziness—Erlotinib—pancreatic cancer	0.00109	0.00135	CcSEcCtD
Sotalol—Purpura—Doxorubicin—pancreatic cancer	0.00107	0.00133	CcSEcCtD
Sotalol—Hypotension—Gemcitabine—pancreatic cancer	0.00107	0.00133	CcSEcCtD
Sotalol—Insomnia—Irinotecan—pancreatic cancer	0.00106	0.00132	CcSEcCtD
Sotalol—Vomiting—Tamoxifen—pancreatic cancer	0.00106	0.00131	CcSEcCtD
Sotalol—Cardiac failure—Doxorubicin—pancreatic cancer	0.00106	0.00131	CcSEcCtD
Sotalol—Mood swings—Epirubicin—pancreatic cancer	0.00106	0.00131	CcSEcCtD
Sotalol—Paraesthesia—Irinotecan—pancreatic cancer	0.00106	0.00131	CcSEcCtD
Sotalol—Lethargy—Doxorubicin—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Sotalol—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Sotalol—Hypotension—Fluorouracil—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Sotalol—Rash—Tamoxifen—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Sotalol—Dermatitis—Tamoxifen—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Sotalol—Vomiting—Erlotinib—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Sotalol—Dyspnoea—Irinotecan—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Sotalol—Somnolence—Irinotecan—pancreatic cancer	0.00105	0.00129	CcSEcCtD
Sotalol—Headache—Tamoxifen—pancreatic cancer	0.00105	0.00129	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00104	0.00129	CcSEcCtD
Sotalol—Rash—Erlotinib—pancreatic cancer	0.00104	0.00129	CcSEcCtD
Sotalol—Dermatitis—Erlotinib—pancreatic cancer	0.00104	0.00129	CcSEcCtD
Sotalol—Angiopathy—Docetaxel—pancreatic cancer	0.00104	0.00129	CcSEcCtD
Sotalol—Insomnia—Gemcitabine—pancreatic cancer	0.00104	0.00128	CcSEcCtD
Sotalol—Dyspepsia—Irinotecan—pancreatic cancer	0.00104	0.00128	CcSEcCtD
Sotalol—Headache—Erlotinib—pancreatic cancer	0.00103	0.00128	CcSEcCtD
Sotalol—Pain in extremity—Doxorubicin—pancreatic cancer	0.00103	0.00128	CcSEcCtD
Sotalol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00103	0.00127	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00103	0.00127	CcSEcCtD
Sotalol—Asthenia—Sunitinib—pancreatic cancer	0.00103	0.00127	CcSEcCtD
Sotalol—Decreased appetite—Irinotecan—pancreatic cancer	0.00102	0.00127	CcSEcCtD
Sotalol—Arrhythmia—Docetaxel—pancreatic cancer	0.00102	0.00127	CcSEcCtD
Sotalol—Dyspnoea—Gemcitabine—pancreatic cancer	0.00102	0.00127	CcSEcCtD
Sotalol—Insomnia—Fluorouracil—pancreatic cancer	0.00102	0.00126	CcSEcCtD
Sotalol—Somnolence—Gemcitabine—pancreatic cancer	0.00102	0.00126	CcSEcCtD
Sotalol—Affect lability—Doxorubicin—pancreatic cancer	0.00102	0.00126	CcSEcCtD
Sotalol—Fatigue—Irinotecan—pancreatic cancer	0.00101	0.00126	CcSEcCtD
Sotalol—Ibuprofen—PTGS2—pancreatic cancer	0.00101	0.147	CrCbGaD
Sotalol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00101	0.00125	CcSEcCtD
Sotalol—Alopecia—Docetaxel—pancreatic cancer	0.00101	0.00125	CcSEcCtD
Sotalol—Pruritus—Sunitinib—pancreatic cancer	0.00101	0.00125	CcSEcCtD
Sotalol—Pain—Irinotecan—pancreatic cancer	0.00101	0.00125	CcSEcCtD
Sotalol—Dyspnoea—Fluorouracil—pancreatic cancer	0.00101	0.00124	CcSEcCtD
Sotalol—Somnolence—Fluorouracil—pancreatic cancer	0.001	0.00124	CcSEcCtD
Sotalol—Decreased appetite—Gemcitabine—pancreatic cancer	0.000997	0.00123	CcSEcCtD
Sotalol—Dyspepsia—Fluorouracil—pancreatic cancer	0.000992	0.00123	CcSEcCtD
Sotalol—Nausea—Tamoxifen—pancreatic cancer	0.000991	0.00123	CcSEcCtD
Sotalol—Fatigue—Gemcitabine—pancreatic cancer	0.000989	0.00122	CcSEcCtD
Sotalol—Pain—Gemcitabine—pancreatic cancer	0.000981	0.00121	CcSEcCtD
Sotalol—Nausea—Erlotinib—pancreatic cancer	0.000981	0.00121	CcSEcCtD
Sotalol—Decreased appetite—Fluorouracil—pancreatic cancer	0.00098	0.00121	CcSEcCtD
Sotalol—Mood swings—Doxorubicin—pancreatic cancer	0.000979	0.00121	CcSEcCtD
Sotalol—Diarrhoea—Sunitinib—pancreatic cancer	0.000978	0.00121	CcSEcCtD
Sotalol—Dysgeusia—Docetaxel—pancreatic cancer	0.000976	0.00121	CcSEcCtD
Sotalol—Abdominal distension—Epirubicin—pancreatic cancer	0.000972	0.0012	CcSEcCtD
Sotalol—Influenza—Epirubicin—pancreatic cancer	0.000965	0.00119	CcSEcCtD
Sotalol—Asthma—Epirubicin—pancreatic cancer	0.000965	0.00119	CcSEcCtD
Sotalol—Back pain—Docetaxel—pancreatic cancer	0.000964	0.00119	CcSEcCtD
Sotalol—Pain—Fluorouracil—pancreatic cancer	0.000964	0.00119	CcSEcCtD
Sotalol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000963	0.00119	CcSEcCtD
Sotalol—Muscle spasms—Docetaxel—pancreatic cancer	0.000959	0.00119	CcSEcCtD
Sotalol—Eosinophilia—Epirubicin—pancreatic cancer	0.000956	0.00118	CcSEcCtD
Sotalol—Dizziness—Sunitinib—pancreatic cancer	0.000945	0.00117	CcSEcCtD
Sotalol—Angina pectoris—Epirubicin—pancreatic cancer	0.00094	0.00116	CcSEcCtD
Sotalol—Abdominal pain—Irinotecan—pancreatic cancer	0.000931	0.00115	CcSEcCtD
Sotalol—Body temperature increased—Irinotecan—pancreatic cancer	0.000931	0.00115	CcSEcCtD
Sotalol—Vomiting—Sunitinib—pancreatic cancer	0.000909	0.00112	CcSEcCtD
Sotalol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000906	0.00112	CcSEcCtD
Sotalol—Rash—Sunitinib—pancreatic cancer	0.000901	0.00111	CcSEcCtD
Sotalol—Dermatitis—Sunitinib—pancreatic cancer	0.0009	0.00111	CcSEcCtD
Sotalol—Abdominal distension—Doxorubicin—pancreatic cancer	0.000899	0.00111	CcSEcCtD
Sotalol—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000897	0.00111	CcSEcCtD
Sotalol—Headache—Sunitinib—pancreatic cancer	0.000895	0.00111	CcSEcCtD
Sotalol—Syncope—Docetaxel—pancreatic cancer	0.000894	0.00111	CcSEcCtD
Sotalol—Asthma—Doxorubicin—pancreatic cancer	0.000893	0.00111	CcSEcCtD
Sotalol—Influenza—Doxorubicin—pancreatic cancer	0.000893	0.00111	CcSEcCtD
Sotalol—Leukopenia—Docetaxel—pancreatic cancer	0.000892	0.0011	CcSEcCtD
Sotalol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000891	0.0011	CcSEcCtD
Sotalol—Eosinophilia—Doxorubicin—pancreatic cancer	0.000884	0.00109	CcSEcCtD
Sotalol—Palpitations—Docetaxel—pancreatic cancer	0.000881	0.00109	CcSEcCtD
Sotalol—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000881	0.00109	CcSEcCtD
Sotalol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000876	0.00108	CcSEcCtD
Sotalol—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000871	0.00108	CcSEcCtD
Sotalol—Cough—Docetaxel—pancreatic cancer	0.00087	0.00108	CcSEcCtD
Sotalol—Angina pectoris—Doxorubicin—pancreatic cancer	0.00087	0.00108	CcSEcCtD
Sotalol—Hypertension—Docetaxel—pancreatic cancer	0.000861	0.00107	CcSEcCtD
Sotalol—Drowsiness—Epirubicin—pancreatic cancer	0.000861	0.00106	CcSEcCtD
Sotalol—Myalgia—Docetaxel—pancreatic cancer	0.000849	0.00105	CcSEcCtD
Sotalol—Chest pain—Docetaxel—pancreatic cancer	0.000849	0.00105	CcSEcCtD
Sotalol—Nausea—Sunitinib—pancreatic cancer	0.000849	0.00105	CcSEcCtD
Sotalol—Asthenia—Irinotecan—pancreatic cancer	0.000845	0.00105	CcSEcCtD
Sotalol—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000844	0.00104	CcSEcCtD
Sotalol—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00083	0.00103	CcSEcCtD
Sotalol—Asthenia—Gemcitabine—pancreatic cancer	0.000823	0.00102	CcSEcCtD
Sotalol—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000815	0.00101	CcSEcCtD
Sotalol—Oedema—Docetaxel—pancreatic cancer	0.000814	0.00101	CcSEcCtD
Sotalol—Pruritus—Gemcitabine—pancreatic cancer	0.000811	0.001	CcSEcCtD
Sotalol—Infection—Docetaxel—pancreatic cancer	0.000808	0.001	CcSEcCtD
Sotalol—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000806	0.000997	CcSEcCtD
Sotalol—Diarrhoea—Irinotecan—pancreatic cancer	0.000805	0.000997	CcSEcCtD
Sotalol—Agranulocytosis—Epirubicin—pancreatic cancer	0.000803	0.000994	CcSEcCtD
Sotalol—Shock—Docetaxel—pancreatic cancer	0.000801	0.000991	CcSEcCtD
Sotalol—Pruritus—Fluorouracil—pancreatic cancer	0.000798	0.000987	CcSEcCtD
Sotalol—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000797	0.000986	CcSEcCtD
Sotalol—Drowsiness—Doxorubicin—pancreatic cancer	0.000796	0.000985	CcSEcCtD
Sotalol—Bradycardia—Epirubicin—pancreatic cancer	0.000786	0.000973	CcSEcCtD
Sotalol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000785	0.000971	CcSEcCtD
Sotalol—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00078	0.000966	CcSEcCtD
Sotalol—Dizziness—Irinotecan—pancreatic cancer	0.000778	0.000963	CcSEcCtD
Sotalol—Haemoglobin—Epirubicin—pancreatic cancer	0.000776	0.000961	CcSEcCtD
Sotalol—Haemorrhage—Epirubicin—pancreatic cancer	0.000773	0.000956	CcSEcCtD
Sotalol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000771	0.000955	CcSEcCtD
Sotalol—Hypotension—Docetaxel—pancreatic cancer	0.00076	0.000941	CcSEcCtD
Sotalol—Vomiting—Irinotecan—pancreatic cancer	0.000748	0.000926	CcSEcCtD
Sotalol—Dizziness—Fluorouracil—pancreatic cancer	0.000746	0.000923	CcSEcCtD
Sotalol—Visual impairment—Epirubicin—pancreatic cancer	0.000744	0.000921	CcSEcCtD
Sotalol—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000743	0.00092	CcSEcCtD
Sotalol—Rash—Irinotecan—pancreatic cancer	0.000742	0.000918	CcSEcCtD
Sotalol—Dermatitis—Irinotecan—pancreatic cancer	0.000741	0.000918	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000741	0.000917	CcSEcCtD
Sotalol—Headache—Irinotecan—pancreatic cancer	0.000737	0.000913	CcSEcCtD
Sotalol—Insomnia—Docetaxel—pancreatic cancer	0.000736	0.000911	CcSEcCtD
Sotalol—Paraesthesia—Docetaxel—pancreatic cancer	0.000731	0.000904	CcSEcCtD
Sotalol—Vomiting—Gemcitabine—pancreatic cancer	0.000729	0.000902	CcSEcCtD
Sotalol—Bradycardia—Doxorubicin—pancreatic cancer	0.000728	0.0009	CcSEcCtD
Sotalol—Dyspnoea—Docetaxel—pancreatic cancer	0.000725	0.000898	CcSEcCtD
Sotalol—Somnolence—Docetaxel—pancreatic cancer	0.000723	0.000895	CcSEcCtD
Sotalol—Rash—Gemcitabine—pancreatic cancer	0.000723	0.000895	CcSEcCtD
Sotalol—Dermatitis—Gemcitabine—pancreatic cancer	0.000722	0.000894	CcSEcCtD
Sotalol—Haemoglobin—Doxorubicin—pancreatic cancer	0.000718	0.000889	CcSEcCtD
Sotalol—Headache—Gemcitabine—pancreatic cancer	0.000718	0.000889	CcSEcCtD
Sotalol—Vomiting—Fluorouracil—pancreatic cancer	0.000717	0.000887	CcSEcCtD
Sotalol—Dyspepsia—Docetaxel—pancreatic cancer	0.000716	0.000886	CcSEcCtD
Sotalol—Haemorrhage—Doxorubicin—pancreatic cancer	0.000715	0.000885	CcSEcCtD
Sotalol—Rash—Fluorouracil—pancreatic cancer	0.000711	0.00088	CcSEcCtD
Sotalol—Dermatitis—Fluorouracil—pancreatic cancer	0.00071	0.000879	CcSEcCtD
Sotalol—Decreased appetite—Docetaxel—pancreatic cancer	0.000707	0.000875	CcSEcCtD
Sotalol—Headache—Fluorouracil—pancreatic cancer	0.000706	0.000874	CcSEcCtD
Sotalol—Fatigue—Docetaxel—pancreatic cancer	0.000702	0.000868	CcSEcCtD
Sotalol—Angiopathy—Epirubicin—pancreatic cancer	0.000701	0.000867	CcSEcCtD
Sotalol—Nausea—Irinotecan—pancreatic cancer	0.000699	0.000865	CcSEcCtD
Sotalol—Pain—Docetaxel—pancreatic cancer	0.000696	0.000861	CcSEcCtD
Sotalol—Arrhythmia—Epirubicin—pancreatic cancer	0.00069	0.000854	CcSEcCtD
Sotalol—Visual impairment—Doxorubicin—pancreatic cancer	0.000689	0.000852	CcSEcCtD
Sotalol—Alopecia—Epirubicin—pancreatic cancer	0.000683	0.000845	CcSEcCtD
Sotalol—Nausea—Gemcitabine—pancreatic cancer	0.000681	0.000843	CcSEcCtD
Sotalol—Nausea—Fluorouracil—pancreatic cancer	0.00067	0.000829	CcSEcCtD
Sotalol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000665	0.000823	CcSEcCtD
Sotalol—Flatulence—Epirubicin—pancreatic cancer	0.000663	0.00082	CcSEcCtD
Sotalol—Dysgeusia—Epirubicin—pancreatic cancer	0.000659	0.000815	CcSEcCtD
Sotalol—Back pain—Epirubicin—pancreatic cancer	0.00065	0.000805	CcSEcCtD
Sotalol—Angiopathy—Doxorubicin—pancreatic cancer	0.000649	0.000803	CcSEcCtD
Sotalol—Muscle spasms—Epirubicin—pancreatic cancer	0.000647	0.0008	CcSEcCtD
Sotalol—Abdominal pain—Docetaxel—pancreatic cancer	0.000643	0.000796	CcSEcCtD
Sotalol—Body temperature increased—Docetaxel—pancreatic cancer	0.000643	0.000796	CcSEcCtD
Sotalol—Arrhythmia—Doxorubicin—pancreatic cancer	0.000639	0.00079	CcSEcCtD
Sotalol—Vision blurred—Epirubicin—pancreatic cancer	0.000634	0.000784	CcSEcCtD
Sotalol—Alopecia—Doxorubicin—pancreatic cancer	0.000632	0.000782	CcSEcCtD
Sotalol—Flatulence—Doxorubicin—pancreatic cancer	0.000613	0.000759	CcSEcCtD
Sotalol—Dysgeusia—Doxorubicin—pancreatic cancer	0.000609	0.000754	CcSEcCtD
Sotalol—Vertigo—Epirubicin—pancreatic cancer	0.000604	0.000748	CcSEcCtD
Sotalol—Syncope—Epirubicin—pancreatic cancer	0.000603	0.000746	CcSEcCtD
Sotalol—Leukopenia—Epirubicin—pancreatic cancer	0.000602	0.000745	CcSEcCtD
Sotalol—Back pain—Doxorubicin—pancreatic cancer	0.000602	0.000745	CcSEcCtD
Sotalol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000598	0.00074	CcSEcCtD
Sotalol—Palpitations—Epirubicin—pancreatic cancer	0.000594	0.000735	CcSEcCtD
Sotalol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000591	0.000731	CcSEcCtD
Sotalol—Cough—Epirubicin—pancreatic cancer	0.000587	0.000726	CcSEcCtD
Sotalol—Vision blurred—Doxorubicin—pancreatic cancer	0.000586	0.000726	CcSEcCtD
Sotalol—Asthenia—Docetaxel—pancreatic cancer	0.000584	0.000722	CcSEcCtD
Sotalol—Hypertension—Epirubicin—pancreatic cancer	0.000581	0.000718	CcSEcCtD
Sotalol—Pruritus—Docetaxel—pancreatic cancer	0.000576	0.000712	CcSEcCtD
Sotalol—Myalgia—Epirubicin—pancreatic cancer	0.000573	0.000708	CcSEcCtD
Sotalol—Chest pain—Epirubicin—pancreatic cancer	0.000573	0.000708	CcSEcCtD
Sotalol—Anxiety—Epirubicin—pancreatic cancer	0.000571	0.000706	CcSEcCtD
Sotalol—Vertigo—Doxorubicin—pancreatic cancer	0.000559	0.000692	CcSEcCtD
Sotalol—Syncope—Doxorubicin—pancreatic cancer	0.000558	0.000691	CcSEcCtD
Sotalol—Leukopenia—Doxorubicin—pancreatic cancer	0.000557	0.000689	CcSEcCtD
Sotalol—Diarrhoea—Docetaxel—pancreatic cancer	0.000557	0.000689	CcSEcCtD
Sotalol—Palpitations—Doxorubicin—pancreatic cancer	0.00055	0.00068	CcSEcCtD
Sotalol—Oedema—Epirubicin—pancreatic cancer	0.000549	0.000679	CcSEcCtD
Sotalol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000547	0.000677	CcSEcCtD
Sotalol—Infection—Epirubicin—pancreatic cancer	0.000545	0.000675	CcSEcCtD
Sotalol—Cough—Doxorubicin—pancreatic cancer	0.000543	0.000672	CcSEcCtD
Sotalol—Shock—Epirubicin—pancreatic cancer	0.00054	0.000668	CcSEcCtD
Sotalol—Dizziness—Docetaxel—pancreatic cancer	0.000538	0.000666	CcSEcCtD
Sotalol—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000537	0.000665	CcSEcCtD
Sotalol—Hypertension—Doxorubicin—pancreatic cancer	0.000537	0.000665	CcSEcCtD
Sotalol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000531	0.000657	CcSEcCtD
Sotalol—Myalgia—Doxorubicin—pancreatic cancer	0.00053	0.000656	CcSEcCtD
Sotalol—Chest pain—Doxorubicin—pancreatic cancer	0.00053	0.000656	CcSEcCtD
Sotalol—Anxiety—Doxorubicin—pancreatic cancer	0.000528	0.000653	CcSEcCtD
Sotalol—Vomiting—Docetaxel—pancreatic cancer	0.000517	0.00064	CcSEcCtD
Sotalol—Rash—Docetaxel—pancreatic cancer	0.000513	0.000635	CcSEcCtD
Sotalol—Hypotension—Epirubicin—pancreatic cancer	0.000513	0.000635	CcSEcCtD
Sotalol—Dermatitis—Docetaxel—pancreatic cancer	0.000513	0.000634	CcSEcCtD
Sotalol—Headache—Docetaxel—pancreatic cancer	0.00051	0.000631	CcSEcCtD
Sotalol—Oedema—Doxorubicin—pancreatic cancer	0.000508	0.000628	CcSEcCtD
Sotalol—Infection—Doxorubicin—pancreatic cancer	0.000505	0.000624	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.0005	0.000619	CcSEcCtD
Sotalol—Shock—Doxorubicin—pancreatic cancer	0.0005	0.000618	CcSEcCtD
Sotalol—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000497	0.000615	CcSEcCtD
Sotalol—Insomnia—Epirubicin—pancreatic cancer	0.000496	0.000614	CcSEcCtD
Sotalol—Paraesthesia—Epirubicin—pancreatic cancer	0.000493	0.00061	CcSEcCtD
Sotalol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000491	0.000608	CcSEcCtD
Sotalol—Dyspnoea—Epirubicin—pancreatic cancer	0.000489	0.000606	CcSEcCtD
Sotalol—Somnolence—Epirubicin—pancreatic cancer	0.000488	0.000604	CcSEcCtD
Sotalol—Nausea—Docetaxel—pancreatic cancer	0.000483	0.000598	CcSEcCtD
Sotalol—Dyspepsia—Epirubicin—pancreatic cancer	0.000483	0.000598	CcSEcCtD
Sotalol—Decreased appetite—Epirubicin—pancreatic cancer	0.000477	0.00059	CcSEcCtD
Sotalol—Hypotension—Doxorubicin—pancreatic cancer	0.000475	0.000587	CcSEcCtD
Sotalol—Fatigue—Epirubicin—pancreatic cancer	0.000473	0.000586	CcSEcCtD
Sotalol—Pain—Epirubicin—pancreatic cancer	0.000469	0.000581	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000463	0.000573	CcSEcCtD
Sotalol—Insomnia—Doxorubicin—pancreatic cancer	0.000459	0.000568	CcSEcCtD
Sotalol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000456	0.000564	CcSEcCtD
Sotalol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000453	0.00056	CcSEcCtD
Sotalol—Somnolence—Doxorubicin—pancreatic cancer	0.000451	0.000559	CcSEcCtD
Sotalol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000449	0.000555	CcSEcCtD
Sotalol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000447	0.000553	CcSEcCtD
Sotalol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000441	0.000546	CcSEcCtD
Sotalol—Fatigue—Doxorubicin—pancreatic cancer	0.000438	0.000542	CcSEcCtD
Sotalol—Pain—Doxorubicin—pancreatic cancer	0.000434	0.000537	CcSEcCtD
Sotalol—Body temperature increased—Epirubicin—pancreatic cancer	0.000434	0.000537	CcSEcCtD
Sotalol—Abdominal pain—Epirubicin—pancreatic cancer	0.000434	0.000537	CcSEcCtD
Sotalol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000415	0.000514	CcSEcCtD
Sotalol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000401	0.000497	CcSEcCtD
Sotalol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000401	0.000497	CcSEcCtD
Sotalol—Asthenia—Epirubicin—pancreatic cancer	0.000394	0.000487	CcSEcCtD
Sotalol—Pruritus—Epirubicin—pancreatic cancer	0.000388	0.000481	CcSEcCtD
Sotalol—Diarrhoea—Epirubicin—pancreatic cancer	0.000376	0.000465	CcSEcCtD
Sotalol—Asthenia—Doxorubicin—pancreatic cancer	0.000364	0.000451	CcSEcCtD
Sotalol—Dizziness—Epirubicin—pancreatic cancer	0.000363	0.000449	CcSEcCtD
Sotalol—Pruritus—Doxorubicin—pancreatic cancer	0.000359	0.000445	CcSEcCtD
Sotalol—Vomiting—Epirubicin—pancreatic cancer	0.000349	0.000432	CcSEcCtD
Sotalol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000347	0.00043	CcSEcCtD
Sotalol—Rash—Epirubicin—pancreatic cancer	0.000346	0.000428	CcSEcCtD
Sotalol—Dermatitis—Epirubicin—pancreatic cancer	0.000346	0.000428	CcSEcCtD
Sotalol—Headache—Epirubicin—pancreatic cancer	0.000344	0.000425	CcSEcCtD
Sotalol—Dizziness—Doxorubicin—pancreatic cancer	0.000336	0.000416	CcSEcCtD
Sotalol—Nausea—Epirubicin—pancreatic cancer	0.000326	0.000403	CcSEcCtD
Sotalol—Vomiting—Doxorubicin—pancreatic cancer	0.000323	0.0004	CcSEcCtD
Sotalol—Rash—Doxorubicin—pancreatic cancer	0.00032	0.000396	CcSEcCtD
Sotalol—Dermatitis—Doxorubicin—pancreatic cancer	0.00032	0.000396	CcSEcCtD
Sotalol—Headache—Doxorubicin—pancreatic cancer	0.000318	0.000394	CcSEcCtD
Sotalol—ADRB1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00031	0.00254	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GDI1—pancreatic cancer	0.00031	0.00253	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GDI2—pancreatic cancer	0.00031	0.00253	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PPY—pancreatic cancer	0.000304	0.00249	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000304	0.00248	CbGpPWpGaD
Sotalol—Nausea—Doxorubicin—pancreatic cancer	0.000302	0.000373	CcSEcCtD
Sotalol—ADRB1—GPCR ligand binding—SST—pancreatic cancer	0.000301	0.00246	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000299	0.00244	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PPY—pancreatic cancer	0.000298	0.00243	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—SST—pancreatic cancer	0.000294	0.00241	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000294	0.0024	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000292	0.00239	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000289	0.00236	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—SSTR3—pancreatic cancer	0.000288	0.00235	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000285	0.00233	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000282	0.00231	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000282	0.0023	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CNR1—pancreatic cancer	0.000278	0.00227	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PPY—pancreatic cancer	0.000276	0.00226	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—SSTR1—pancreatic cancer	0.000276	0.00225	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CNR1—pancreatic cancer	0.000272	0.00222	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000271	0.00222	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PPY—pancreatic cancer	0.00027	0.00221	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—GCG—pancreatic cancer	0.000268	0.00219	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—SSTR2—pancreatic cancer	0.000265	0.00217	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—GCG—pancreatic cancer	0.000262	0.00214	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000262	0.00214	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCKBR—pancreatic cancer	0.000256	0.00209	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000256	0.00209	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—AGTR1—pancreatic cancer	0.00025	0.00205	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GAST—pancreatic cancer	0.000248	0.00203	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GAST—pancreatic cancer	0.000243	0.00198	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—SCT—pancreatic cancer	0.000235	0.00192	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—SCT—pancreatic cancer	0.00023	0.00188	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GAST—pancreatic cancer	0.000225	0.00184	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCK—pancreatic cancer	0.000224	0.00183	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GAST—pancreatic cancer	0.00022	0.0018	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCK—pancreatic cancer	0.00022	0.00179	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000219	0.00179	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000219	0.00179	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000215	0.00176	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CNR2—pancreatic cancer	0.000214	0.00175	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000214	0.00175	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—SCT—pancreatic cancer	0.000214	0.00175	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00021	0.00172	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—SCT—pancreatic cancer	0.000209	0.00171	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRLHR—pancreatic cancer	0.000204	0.00167	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCK—pancreatic cancer	0.000204	0.00167	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRLHR—pancreatic cancer	0.0002	0.00163	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCK—pancreatic cancer	0.000199	0.00163	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CNR2—pancreatic cancer	0.000199	0.00162	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000199	0.00162	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000195	0.0016	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CNR2—pancreatic cancer	0.000194	0.00159	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000194	0.00159	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000194	0.00158	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000192	0.00157	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000192	0.00157	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000191	0.00156	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000189	0.00155	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000188	0.00154	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000188	0.00154	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000186	0.00152	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000182	0.00149	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—SHH—pancreatic cancer	0.000178	0.00146	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IAPP—pancreatic cancer	0.000176	0.00144	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—SHH—pancreatic cancer	0.000174	0.00142	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SSTR3—pancreatic cancer	0.000174	0.00142	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—DTX1—pancreatic cancer	0.000174	0.00142	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IAPP—pancreatic cancer	0.000172	0.00141	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—SST—pancreatic cancer	0.00017	0.00139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—DTX1—pancreatic cancer	0.00017	0.00139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SSTR3—pancreatic cancer	0.00017	0.00139	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000169	0.00138	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000169	0.00138	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	0.000167	0.00136	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	0.000166	0.00136	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000165	0.00135	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000165	0.00135	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	0.000163	0.00133	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.000163	0.00133	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	0.00016	0.00131	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	0.00016	0.00131	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000157	0.00128	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	0.000157	0.00128	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	0.000155	0.00126	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	0.000154	0.00126	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000154	0.00126	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000154	0.00125	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	0.000152	0.00124	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	0.000151	0.00124	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	0.000151	0.00123	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—HRAS—pancreatic cancer	0.000151	0.00123	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000151	0.00123	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	0.000148	0.00121	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	0.000146	0.00119	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	0.000146	0.00119	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000145	0.00118	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	0.000143	0.00116	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	0.000142	0.00116	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	0.000142	0.00116	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	0.000142	0.00116	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000142	0.00116	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000141	0.00116	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.000139	0.00114	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000138	0.00113	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000138	0.00113	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	0.000138	0.00112	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	0.000136	0.00111	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000135	0.0011	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	0.000133	0.00109	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	0.000133	0.00109	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000131	0.00107	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	0.00013	0.00106	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000128	0.00105	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	0.000126	0.00103	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	0.000126	0.00103	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000123	0.00101	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	0.000123	0.00101	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	0.00012	0.000984	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	0.000118	0.000962	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	0.000117	0.000959	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	0.000117	0.000959	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000117	0.000958	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	0.000115	0.000943	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	0.000115	0.000938	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.000115	0.000938	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000115	0.000937	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000113	0.000923	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	0.000112	0.000915	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	0.00011	0.000901	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	0.000109	0.000895	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	0.000108	0.000882	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	0.000105	0.00086	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000105	0.000854	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	0.000104	0.000849	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	0.000103	0.000841	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000102	0.000836	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	0.000102	0.000831	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	9.98e-05	0.000815	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	9.98e-05	0.000815	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	9.76e-05	0.000797	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	9.76e-05	0.000797	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SST—pancreatic cancer	9.12e-05	0.000746	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	9e-05	0.000735	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	8.93e-05	0.00073	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SST—pancreatic cancer	8.92e-05	0.000729	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	8.89e-05	0.000727	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.8e-05	0.000719	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	8.73e-05	0.000714	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	8.7e-05	0.000711	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	8.42e-05	0.000688	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	8.24e-05	0.000673	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	8.17e-05	0.000668	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	8.13e-05	0.000664	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	7.99e-05	0.000653	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	7.95e-05	0.00065	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.91e-05	0.000646	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	7.76e-05	0.000634	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.74e-05	0.000632	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	7.65e-05	0.000625	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	7.59e-05	0.00062	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	7.48e-05	0.000611	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	7.18e-05	0.000587	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	7.03e-05	0.000574	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.89e-05	0.000563	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.74e-05	0.000551	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	6.7e-05	0.000547	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	6.63e-05	0.000541	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	6.55e-05	0.000535	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	6.54e-05	0.000534	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	6.48e-05	0.00053	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	6.4e-05	0.000523	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	6.26e-05	0.000512	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	6.12e-05	0.000501	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	6.02e-05	0.000492	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	5.89e-05	0.000481	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	5.73e-05	0.000468	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	5.6e-05	0.000458	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	5.48e-05	0.000448	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	5.47e-05	0.000447	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	5.36e-05	0.000438	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	5.35e-05	0.000437	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	5.35e-05	0.000437	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	5.24e-05	0.000428	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	5.23e-05	0.000428	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	5.13e-05	0.000419	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	4.98e-05	0.000407	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	4.94e-05	0.000403	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	4.88e-05	0.000398	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	4.83e-05	0.000395	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	4.83e-05	0.000394	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	4.83e-05	0.000394	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	4.77e-05	0.00039	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	4.72e-05	0.000386	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	4.72e-05	0.000386	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	4.67e-05	0.000381	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	4.4e-05	0.000359	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	4.3e-05	0.000352	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	4.24e-05	0.000347	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.2e-05	0.000343	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	4.15e-05	0.000339	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	4.15e-05	0.000339	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.11e-05	0.000336	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	4.06e-05	0.000332	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.82e-05	0.000312	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.73e-05	0.000305	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	3.7e-05	0.000302	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	3.62e-05	0.000296	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	3.55e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	3.53e-05	0.000289	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	3.48e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	3.45e-05	0.000282	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	3.43e-05	0.000281	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	3.4e-05	0.000278	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	3.36e-05	0.000274	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	3.33e-05	0.000272	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	3.31e-05	0.000271	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	3.28e-05	0.000268	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	3.24e-05	0.000265	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	3.21e-05	0.000263	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	3.21e-05	0.000262	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	3.2e-05	0.000261	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	3.14e-05	0.000257	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	3.13e-05	0.000255	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	3.12e-05	0.000255	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	3.05e-05	0.000249	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	2.96e-05	0.000242	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	2.9e-05	0.000237	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	2.89e-05	0.000236	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	2.86e-05	0.000234	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	2.85e-05	0.000233	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	2.82e-05	0.000231	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	2.8e-05	0.000228	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	2.79e-05	0.000228	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	2.66e-05	0.000217	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	2.65e-05	0.000217	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	2.6e-05	0.000212	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	2.6e-05	0.000212	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	2.59e-05	0.000212	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	2.54e-05	0.000208	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	2.45e-05	0.000201	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	2.4e-05	0.000196	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	2.25e-05	0.000184	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	2.21e-05	0.00018	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	2.18e-05	0.000178	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	2.13e-05	0.000174	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.09e-05	0.00017	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	2.04e-05	0.000167	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	1.84e-05	0.000151	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	1.8e-05	0.000147	CbGpPWpGaD
